London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
You will only have one login account. Registering with multiple accounts is not allowed. Any user found to have more than one account on this site will have all, and any future accounts suspended permanently.
Your email and password must only be used by you. If a post is made under your account, it will be considered that it was posted by yourself.
Your account nickname must not be the same, or contain, listed company names or board members' names.
While debating and discussion is fine, we will not tolerate; rudeness, swearing, insulting posts, personal attacks, or posts which are invasive of another's privacy.
You will not;
discuss illegal or criminal activities.
post any confidential or price sensitive information or that is not public knowledge.
post misleading or false statements regarding the share price and performance. Such posts are deemed as market abuse, and may be reported to the appropriate authorities.
post any private communication, or part thereof, from any other person, including from a member of the board of directors of a listed company. Such posts cannot be verified as true and could be deemed to be misleading.
post any personal details (e.g. email address or phone number).
post live price or level 2 updates.
publish content that is not your original work, or infringes the copyright or other rights of any third party.
post non-constructive, meaningless, one word (or short) non-sense posts.
post links to, or otherwise publish any content containing any form of advertising, promotion for goods and services, spam, or other unsolicited communication.
post any affiliate or referral links, or post anything asking for a referral.
post or otherwise publish any content unrelated to the board or the board's topic.
re-post premium share chat posts on regular share chat.
restrict or inhibit any other user from using the boards.
impersonate any person or entity, including any of our employees or representatives.
post or transmit any content that contains software viruses, files or code designed to interrupt, destroy or limit the functionality of this website or any computer software or equipment.
If you are going to post non-English, please also post an English translation of your post.
If you are going to post non-English, please also post an English translation of your post.
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium and Verified Members
Premium Members are members that have a premium subscription with London South East and have access to Premium Chat. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
The trouble is people are to scared to put in more fearing further dilution. We need solid news on what the money is being spent on with firm timelines and outcomes. An alternative finance plan altough I would think that is doubtful and new interest and volume.
The true thing is leople have pjmped this share from start of last year and hope to get some results out.all good post and all research show that promise so much butthe really thing is not as fast and good as leople dreaming and let come back the true thing is really righ now. Just said the true thing first and hope that on some time they said good mean is good outcome.
There is nothing in this year as Vlad said maybe CART trial next year and take time to get data back.there is no clearn road map for CDX . They said trial but time frame is not clear and the most ghing now is Mint get out with millions share to sell . Who is goinv to buy it? What will Hemi do on next year when 12 millions fund run out? Human trial cost a lot money too and what will they do if no one can help them with fund they need.
Why do you think many trader in here? If you buy Hemo share and expect next rise to sell so again money is the main force for you too. Only difference is time frame. You mah think yesrs . Someone think months. All is base on money so you are not better than other in here. Trader. Short.long.investor only is look after money that is the most important thing to care. Doyou think and support company for development cancer drug to help people or just hope Hemo share up and sell for big gain?
Thats because we dont have a choice but to try to recover our losses. Its hard to work out true value in any timeframe since it would all be based on assumptions. All we know mint will dilute the share price and unless they are removed or the company gets a big deal soon, it will be hard to stay above 2p. I am trying to be positive but its killed my believe in the ceo and management
Bo, I don't think we will go sub 1p, but that is just my opinion. However, I do think we will settle between 1-2p. There are just too many unknowns at the moment. How many more CLNs will Mint sell etc? I used to hold a fair few shares at one stage, sold the lot at a considerable loss, bought back in again twice and now have only 500k in shares with an average of 2.8p. I want to buy a fair few more yet, but I'm holding and waiting at the moment. I do think Hemo will come good eventually, but not for quite a while yet. Let's hope Vlad has a rabbit he can pull out of a hat soon.
Let vlad do the talking......I think that has already cost ordinary pi's a whole lot of money and who knows, maybe even the deal with lily.
Let's face it folks....vlad is a very poor ceo and if recent performance is anything to go by then the bod and nomad leave a lot to be desired also.
I'm afraid we cant judge vlads ability as a scientist although I would be inclined to believe he is a good one and maybe even a great one but hes not ceo material.
That twitter behaviour last year and early this year was well out of order regardless if it was on his personal account or not....if I was part of the lily team then I might have had 2nd thoughts also.
Yes from the RNS on Covid research and the next RNS on break thought on research so I bought and waiting for the result out. what time they make its research out over 1 year and really nothing only names CBR , We dont know how long do it take to trial that drug so more time to wait? some research is over 3 years until nothing get out too. We need see something out not only on paper and people start to think how fast this company to work out. we know they got everything but prove it to work is the most important thing we want to see .
it is not PI or market. it is not MMS bring it down , Mint cant bring down they want it up so they can sell higher price to market . it is all Hemo make it down on hope and disappointment. that need correct on time and take time to make it work out . that is why update on next step is very important to help share up and all we hope on that sooner .
Are you choosing to ignore that we are now at the same SP as pre-covid? And not much further ahead in terms of research progress. The rise in SP last year was due to covid. Arguably, Hemo is now much worse off because it has lost the opportunity of Global taking CDX option and it now has CLN. The recent article by TMS has also tried to play down the covid influence. So that makes me wonder if there is nothing to see there with CBX or whatever the catchy name is.
JHFH, it's not just tuan that sees little value in pre clinical intellectual property. It's the whole market, including potential funders. Otherwise, Hemo would not be in this situation! That's the whole point of clinical trials, to prove the value. Wow, it's not tuan who has a lack of understanding of scientific trials.
It's Saturday, hot tub fixed, not worth long reply. If hemo had not already proven they had something they never would have signed with Penn / J&j / Eli / etc.... Not sure of your motivation, don't really care, I'll let vlad do the talking.
I am wonder why people just buy Hemo shares and wait 5 year then come back here so can sell over 50 times as Hemo at that time become billion CAP company. dont need come here to chat any way.
There is some degree people like certain thing to make sure it is worth to wait or that is worthless. Yes market like to see face value and certain on forward future and moving quick if they can show it work. but let say people buy and hold over year not many people like that way . and the market show that all the time.
I never say Hemo not worth but they need to show how the processed is going on and time frame to get something back to certain thing. that is now and they need RNS to show it . There are many good report on paper but nothing really moving quick only make it less attractive.
Mint is selling off CNL just show big investor want to take money back and no time to wait that is real now Pis are on small scare can wait depend on personals but not all so the last is who right is the time frame the same money can earn most that is the main thing in here.Hemo is good. they got money, they got everything now in state to move to trial the market need to hear how fast they can do their job and market will respond very quick if they can bring anything positive. News is the most thing we are waiting in here .
The fundamental issue with Tuan is they see zero value in pre clinical Intellectual Property. They have zero comprehension of the worth of the research done to date by Hemogenyx. I am not sure if its deliberately so or a genuine lack of understanding.